• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从. 中纯化的全长多巴胺转运蛋白的药理学特性

Pharmacological Characterization of Purified Full-Length Dopamine Transporter from .

机构信息

Laboratory for Membrane Protein Dynamics, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

出版信息

Cells. 2022 Nov 28;11(23):3811. doi: 10.3390/cells11233811.

DOI:10.3390/cells11233811
PMID:36497070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9740255/
Abstract

The dopamine transporter (DAT) is a member of the neurotransmitter:sodium symporter (NSS) family, mediating the sodium-driven reuptake of dopamine from the extracellular space thereby terminating dopaminergic neurotransmission. Our current structural understanding of DAT is derived from the resolutions of DAT from (dDAT). Despite extensive structural studies of purified dDAT in complex with a variety of antidepressants, psychostimulants and its endogenous substrate, dopamine, the molecular pharmacology of purified, full length dDAT is yet to be elucidated. In this study, we functionally characterized purified, full length dDAT in detergent micelles using radioligand binding with the scintillation proximity assay. We elucidate the consequences of Na and Cl binding on [H]nisoxetine affinity and use this to evaluate the binding profiles of substrates and inhibitors to the transporter. Additionally, the technique allowed us to directly determine a equilibrium binding affinity (K) for [H]dopamine to dDAT. To compare with a more native system, the affinities of specified monoamines and inhibitors was determined on dDAT, human DAT and human norepinephrine transporter expressed in COS-7 cells. With our gathered data, we established a pharmacological profile for purified, full length dDAT that will be useful for subsequent biophysical studies using dDAT as model protein for the mammalian NSS family of proteins.

摘要

多巴胺转运体(DAT)是神经递质:钠离子协同转运体(NSS)家族的一员,介导多巴胺从细胞外空间的钠离子驱动重摄取,从而终止多巴胺能神经传递。我们目前对 DAT 的结构理解来自 DAT 的分辨率(dDAT)。尽管对与各种抗抑郁药、精神兴奋剂及其内源性底物多巴胺复合的纯化 dDAT 进行了广泛的结构研究,但纯化全长 dDAT 的分子药理学尚未阐明。在这项研究中,我们使用闪烁接近测定法通过放射性配体结合来功能表征去污剂胶束中的纯化全长 dDAT。我们阐明了 Na 和 Cl 结合对 [H]nisoxetine 亲和力的影响,并利用这一点来评估底物和抑制剂对转运体的结合谱。此外,该技术允许我们直接确定 [H]多巴胺与 dDAT 的平衡结合亲和力(K)。为了与更天然的系统进行比较,在 COS-7 细胞中表达的 dDAT、人 DAT 和人去甲肾上腺素转运体上测定了指定单胺和抑制剂的亲和力。根据我们收集的数据,我们为纯化的全长 dDAT 建立了药理学特征,这将有助于随后使用 dDAT 作为哺乳动物 NSS 蛋白家族的模型蛋白进行生物物理研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/74641264c68f/cells-11-03811-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/55a8765a76d1/cells-11-03811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/e3f5cd9a3664/cells-11-03811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/9139885b8302/cells-11-03811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/82eb03afd79d/cells-11-03811-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/719a07875c39/cells-11-03811-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/74641264c68f/cells-11-03811-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/55a8765a76d1/cells-11-03811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/e3f5cd9a3664/cells-11-03811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/9139885b8302/cells-11-03811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/82eb03afd79d/cells-11-03811-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/719a07875c39/cells-11-03811-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f7a/9740255/74641264c68f/cells-11-03811-g006.jpg

相似文献

1
Pharmacological Characterization of Purified Full-Length Dopamine Transporter from .从. 中纯化的全长多巴胺转运蛋白的药理学特性
Cells. 2022 Nov 28;11(23):3811. doi: 10.3390/cells11233811.
2
The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.果蝇中对抗抑郁药敏感的多巴胺转运体:儿茶酚胺的原始载体。
Mol Pharmacol. 2001 Jan;59(1):83-95. doi: 10.1124/mol.59.1.83.
3
Structural Determinants of the Dopamine Transporter Regulation Mediated by G Proteins.G 蛋白介导的多巴胺转运体调节的结构决定因素。
J Chem Inf Model. 2020 Jul 27;60(7):3577-3586. doi: 10.1021/acs.jcim.0c00236. Epub 2020 Jun 22.
4
Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions.sigma-1 受体与多巴胺转运体的关联通过独特的螺旋-螺旋相互作用减弱了 methamphetamine 的结合。
Chem Biol Drug Des. 2021 Jun;97(6):1194-1209. doi: 10.1111/cbdd.13841. Epub 2021 Apr 4.
5
Functional Rescue of a Misfolded Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones.通过药理学伴侣对与失眠表型相关的错误折叠多巴胺转运体突变体进行功能拯救
J Biol Chem. 2016 Sep 30;291(40):20876-20890. doi: 10.1074/jbc.M116.737551. Epub 2016 Aug 1.
6
Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.多巴胺能 Ric GTP 酶活性以多巴胺转运蛋白依赖的方式影响果蝇对安非他命的敏感性和睡眠质量。
Mol Psychiatry. 2021 Dec;26(12):7793-7802. doi: 10.1038/s41380-021-01275-y. Epub 2021 Sep 1.
7
Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.非保守残基决定了多巴胺转运体对强效合成卡西酮和精神兴奋剂 MDPV 的选择性。
Neuropharmacology. 2021 Dec 1;200:108820. doi: 10.1016/j.neuropharm.2021.108820. Epub 2021 Oct 4.
8
The Role of the Dopamine Transporter in the Effects of Amphetamine on Sleep and Sleep Architecture in Drosophila.多巴胺转运体在安非他命对果蝇睡眠和睡眠结构的影响中的作用。
Neurochem Res. 2022 Jan;47(1):177-189. doi: 10.1007/s11064-021-03275-4. Epub 2021 Feb 25.
9
Functional characterization of dopamine transporter in vivo using Drosophila melanogaster behavioral assays.利用黑腹果蝇行为学实验对体内多巴胺转运体进行功能表征。
Front Behav Neurosci. 2014 Sep 3;8:303. doi: 10.3389/fnbeh.2014.00303. eCollection 2014.
10
Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site.与结合于正构位点的新型非典型非竞争性抑制剂结合的多巴胺转运体的冷冻电镜结构。
J Neurochem. 2024 Sep;168(9):2043-2055. doi: 10.1111/jnc.16179. Epub 2024 Jul 15.

引用本文的文献

1
Structure of the human dopamine transporter in complex with cocaine.人多巴胺转运体与可卡因复合物的结构。
Nature. 2024 Aug;632(8025):678-685. doi: 10.1038/s41586-024-07804-3. Epub 2024 Aug 7.

本文引用的文献

1
The dopamine transporter antiports potassium to increase the uptake of dopamine.多巴胺转运体反向转运钾以增加多巴胺的摄取。
Nat Commun. 2022 May 4;13(1):2446. doi: 10.1038/s41467-022-30154-5.
2
Illumination of serotonin transporter mechanism and role of the allosteric site.血清素转运体机制及变构位点作用的阐明。
Sci Adv. 2021 Dec 3;7(49):eabl3857. doi: 10.1126/sciadv.abl3857. Epub 2021 Dec 1.
3
Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters.神经递质转运体中去甲肾上腺素识别和转运抑制的结构基础。
Nat Commun. 2021 Apr 13;12(1):2199. doi: 10.1038/s41467-021-22385-9.
4
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration.关注人类单胺转运体选择性。新型人 DAT 和 NET 模型,实验验证及 SERT 亲和力研究。
ACS Chem Neurosci. 2020 Oct 21;11(20):3214-3232. doi: 10.1021/acschemneuro.0c00304. Epub 2020 Oct 13.
5
Precision Medicine for Idiopathic Hypersomnia.特发性嗜睡症的精准医学
Sleep Med Clin. 2019 Sep;14(3):333-350. doi: 10.1016/j.jsmc.2019.05.007.
6
Substrate-induced conformational dynamics of the dopamine transporter.底物诱导多巴胺转运体的构象动力学。
Nat Commun. 2019 Jun 20;10(1):2714. doi: 10.1038/s41467-019-10449-w.
7
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.5-羟色胺转运体-伊博格碱复合物阐明了抑制和转运的机制。
Nature. 2019 May;569(7754):141-145. doi: 10.1038/s41586-019-1135-1. Epub 2019 Apr 24.
8
Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation.在抑制剂和变构配体结合构象下稳定人多巴胺转运体(hDAT)并进行纯化。
PLoS One. 2018 Jul 2;13(7):e0200085. doi: 10.1371/journal.pone.0200085. eCollection 2018.
9
Structural basis for recognition of diverse antidepressants by the human serotonin transporter.人类血清素转运蛋白识别多种抗抑郁药的结构基础。
Nat Struct Mol Biol. 2018 Feb;25(2):170-175. doi: 10.1038/s41594-018-0026-8. Epub 2018 Jan 29.
10
Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.3α-[双(4-氟苯基)甲氧基]托烷和 3α-[双(4-氟苯基)甲氨基]托烷系列化合物作为新型非典型多巴胺转运体(DAT)抑制剂的构效关系研究及其在可卡因使用障碍治疗中的应用。
J Med Chem. 2017 Dec 28;60(24):10172-10187. doi: 10.1021/acs.jmedchem.7b01454. Epub 2017 Dec 11.